Status: current, Defined. Date: 30-Sep 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4747251000168117 | nusinersen 12 mg / 5 mL intrathecal injection, 5 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4747261000168115 | nusinersen 12 mg/5 mL intrathecal injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| nusinersen 12 mg/5 mL intrathecal injection, vial | Is a | nusinersen | true | Inferred relationship | Some | ||
| nusinersen 12 mg/5 mL intrathecal injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| nusinersen 12 mg/5 mL intrathecal injection, vial | has manufactured dose form | intrathecal injection | true | Inferred relationship | Some | ||
| nusinersen 12 mg/5 mL intrathecal injection, vial | has intended active ingredient | nusinersen | true | Inferred relationship | Some | 1706027221 | |
| nusinersen 12 mg/5 mL intrathecal injection, vial | has Australian BoSS | nusinersen | true | Inferred relationship | Some | 1706027221 | |
| nusinersen 12 mg/5 mL intrathecal injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1488211363 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Spinraza 12 mg/5 mL intrathecal injection, 5 mL vial | Is a | True | nusinersen 12 mg/5 mL intrathecal injection, vial | Inferred relationship | Some | |
| nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial | has MPUU | True | nusinersen 12 mg/5 mL intrathecal injection, vial | Inferred relationship | Some | 1805011149 |
Reference Sets
Medicinal product unit of use reference set
FHIR